Date published: 2026-3-3

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZPI Inhibitors

ZPI inhibitors refer to a class of chemical compounds that specifically target and inhibit the activity of the ZPI (Zinc-dependent proteinase inhibitor) family of enzymes. ZPI, as a protein, plays a key role in regulating the activity of various proteolytic enzymes, often through its interaction with zinc ions. These enzymes are involved in catalytic processes such as proteolysis, where proteins are broken down into smaller polypeptides or amino acids. Inhibition of ZPI enzymes disrupts this regulatory mechanism, which can affect a range of biological processes. The design and synthesis of ZPI inhibitors focus on blocking the active site of the enzyme, typically where zinc ions coordinate with the enzyme's functional groups. ZPI inhibitors often feature ligand groups that can chelate the zinc ion, thereby rendering the enzyme inactive.

The structural diversity of ZPI inhibitors is an important aspect of their chemical nature, as different inhibitors may bind through various mechanisms, including covalent and non-covalent interactions. These inhibitors are studied to understand the molecular architecture of ZPI enzymes and their roles in biochemical pathways. Advanced techniques like X-ray crystallography and molecular docking are commonly used to study the binding affinity and conformational changes induced by ZPI inhibitors. Furthermore, the chemical synthesis of these inhibitors may involve a variety of organic reactions to optimize their binding efficacy and selectivity for ZPI enzymes, including modifications to enhance metal chelation properties. The study of these inhibitors provides insights into the broader mechanisms of metalloprotease regulation and enzymatic control at the molecular level.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can inhibit the proteasomal degradation of IκB, which sequesters NF-κB in the cytoplasm, preventing its translocation to the nucleus and subsequent binding to the ZPI gene promoter. This inhibition would result in a decrease in ZPI transcription.

Chetomin

1403-36-7sc-202535
sc-202535A
1 mg
5 mg
$186.00
$674.00
10
(1)

Chetomin may disrupt the interaction between hypoxia-inducible factors (HIF) and the coactivator p300/CBP. If ZPI expression is driven by HIF-mediated transcription under hypoxic conditions, chetomin could lead to the downregulation of ZPI expression by inhibiting this interaction.